Related Experiment Video
Updated: Aug 14, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin
Debbi MacMillan1, Susan Currie, Karen N Bradley
1Institute of Biomedical and Life Sciences, Neuroscience and Biomedical Systems, West Medical Building, University of Glasgow, Glasgow, G12 8QQ, UK.
Abstract:
Ca2+ release from the sarcoplasmic reticulum (SR) by the IP3 receptors (IP3Rs) crucially regulates diverse cell signalling processes from reproduction to apoptosis. Release from the IP3R may be modulated by endogenous proteins associated with the receptor, such as the 12 kDa FK506-binding protein (FKBP12), either directly or indirectly by inhibition of the phosphatase calcineurin. Here, we report that, in addition to calcineurin, FKPBs modulate release through the mammalian target of rapamycin (mTOR), a kinase that potentiates Ca2+ release from the IP3R in smooth muscle. The presence of FKBP12 was confirmed in colonic myocytes and co-immunoprecipitated with the IP3R. In aortic smooth muscle, however, although present, FKBP12 did not co-immunoprecipitate with IP3R. In voltage-clamped single colonic myocytes rapamycin, which together with FKBP12 inhibits mTOR (but not calcineurin), decreased the rise in cytosolic Ca2+ concentration ([Ca2+]c) evoked by IP3R activation (by photolysis of caged IP3), without decreasing the SR luminal Ca2+ concentration ([Ca2+]l) as did the mTOR inhibitors RAD001 and LY294002. However, FK506, which with FKBP12 inhibits calcineurin (but not mTOR), potentiated the IP3-evoked [Ca2+]c increase. This potentiation was due to the inhibition of calcineurin; it was mimicked by the phosphatase inhibitors cypermethrin and okadaic acid. The latter two inhibitors also prevented the FK506-evoked increase as did a calcineurin inhibitory peptide (CiP). In aortic smooth muscle, where FKBP12 was not associated with IP3R, the IP3-mediated Ca2+ release was unaffected by FK506 or rapamycin. Together, these results suggest that FKBP12 has little direct effect on IP3-mediated Ca2+ release, even though it is associated with IP3R in colonic myocytes. However, FKBP12 might indirectly modulate Ca2+ release through two effector proteins: (1) mTOR, which potentiates and (2) calcineurin, which inhibits Ca2+ release from IP3R in smooth muscle.
Insights
The 12 kDa FK506-binding protein (FKBP12) indirectly modulates calcium (Ca2+) release through IP3 receptors (IP3Rs) in smooth muscle. FKBP12 interacts with mTOR to potentiate and calcineurin to inhibit Ca2+ release via IP3Rs.
Area of Science:
- Cell Biology
- Molecular Biology
- Physiology
Background:
- Calcium (Ca2+) release from the sarcoplasmic reticulum (SR) via inositol trisphosphate receptors (IP3Rs) is vital for cellular signaling.
- The 12 kDa FK506-binding protein (FKBP12) is known to associate with IP3Rs and modulate their activity, potentially through interactions with calcineurin.
Purpose of the Study:
- To investigate the role of FKBP12 in modulating Ca2+ release through IP3Rs in smooth muscle.
- To determine whether FKBP12 interacts with mammalian target of rapamycin (mTOR) or calcineurin to influence IP3R-mediated Ca2+ release.
Main Methods:
- Co-immunoprecipitation to assess FKBP12 and IP3R association in colonic and aortic myocytes.
- Electrophysiological recordings (voltage-clamp) in single myocytes to measure cytosolic Ca2+ concentration ([Ca2+]c) changes upon IP3R activation.
- Pharmacological inhibition of mTOR (rapamycin, RAD001, LY294002) and calcineurin (FK506, calcineurin inhibitory peptide) to assess their effects on Ca2+ release.
Main Results:
- FKBP12 co-immunoprecipitated with IP3R in colonic myocytes but not in aortic smooth muscle.
- In colonic myocytes, rapamycin (mTOR inhibitor) decreased IP3-evoked [Ca2+]c rise, while FK506 (calcineurin inhibitor) potentiated it.
- In aortic smooth muscle, FK506 and rapamycin did not affect IP3-mediated Ca2+ release, correlating with the lack of FKBP12-IP3R association.
Conclusions:
- FKBP12 indirectly modulates IP3R-mediated Ca2+ release in smooth muscle through interactions with both mTOR and calcineurin.
- mTOR potentiates Ca2+ release, while calcineurin inhibits it, with FKBP12 acting as a scaffold or regulator for these interactions.
- The association of FKBP12 with IP3R is crucial for its modulatory role, as observed in colonic myocytes but not aortic smooth muscle.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
IP3/DAG Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Nitric Oxide Signaling Pathway
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...

